Skip to content
Application 021011
- Type
- NDA
- Sponsor
- SPECGX LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ROXICODONE | OXYCODONE HYDROCHLORIDE | TABLET;ORAL | 15MG | Yes | Yes |
| 002 | ROXICODONE | OXYCODONE HYDROCHLORIDE | TABLET;ORAL | 30MG | Yes | No |
| 003 | ROXICODONE | OXYCODONE HYDROCHLORIDE | TABLET;ORAL | 5MG | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 23635-580 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-580 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-580 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-580 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-581 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-581 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-581 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-581 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-581 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-581 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-582 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-582 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-582 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-582 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-582 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |
| 23635-582 | Roxicodone | oxycodone hydrochloride | SpecGx LLC | NDA | Current |